Cibc Private Wealth Group, LLC Immuneering Corp Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Immuneering Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 10,000 shares of IMRX stock, worth $21,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$21,900% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
41Shares Held
4.64MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.34 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.17 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$983,9910.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$539,3310.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $57.8M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...